Kathleen Alyce Waters

Chief Legal & Public Affairs Officer of DaVita sells 15,405 shares at blended $208.40; stock currently $210.58, near 52-week high of $213.44.

Kathleen Alyce Waters executed 2 separate sales totaling 15,405 shares for $3,210,376.79 on 2026-06-15, reducing her holdings from 124,599 to 109,194 shares (-12.4%). The stock has appreciated +5.5% over the past 30 days and +40.6% over the past 90 days, trading at $210.58—just 1.3% below the 52-week high of $213.44. At DaVita specifically, Waters' prior 3 trades show mixed timing: 2 of 3 generated positive 90-day returns (2024-08-13 at +5.7%, 2024-02-21 at +14.9%), while only 1 of the 3 prior sells was well-timed at the 90-day mark (33.33% timing success rate). Fundamentals remain solid with a P/E of 17.30, annual revenue growth of +6.5%, and $197.5M net income on $3.4B quarterly revenue. The sale occurs in a strong price environment without identifiable distress signals in the company's recent financial performance.

Chief Legal Officer Kathleen Waters sells 7,857 DVA shares at $146.21; stock now at $149.96, near 52-week high.

Kathleen Alyce Waters, Chief Legal & Public Affairs Officer, sold 7,857 shares of DaVita Inc. (DVA) at $146.21 on 2024-08-13, reducing her holdings from 90,868 to 83,011 shares. The sale occurred at a price within the 52-week range and has since underperformed: the stock trades at $149.96 today (+0.0% from the 52-week high), meaning Waters sold before the stock's recent rise. Across her open-market history, her prior 3 sells posted an average 30-day return of +3.3% and 90-day return of +7.4%, with only 33.33% well-timed at the 90-day mark—a mixed record. At this specific ticker (DVA), her prior 3 trades show variable timing: the most recent sell (2024-02-21) returned +11.1% in 30 days and +14.9% in 90 days, both poorly timed for a seller. The transaction reflects a modest 8.6% reduction in her DVA position, not a wholesale exit. The company's fundamentals remain solid with $3.2B in quarterly revenue, $222.7M net income, and a 14.63 P/E ratio.